Olecranon Bursitis Workup
- Author: J Michael Wieting, DO, MEd, FAOCPMR, FAAPMR; Chief Editor: Stephen Kishner, MD, MHA more...
Usually, laboratory studies are necessary only if the clinician suspects that an underlying condition is present. It is necessary to check for infection (complete blood count [CBC], including a differential count of the white blood cells [WBCs]). Tests should also be run for rheumatoid factor, the erythrocyte sedimentation rate, and the C-reactive protein level, in order to assess for rheumatoid arthritis. The uric acid level should be checked in order to assess for gout.
If infection is suspected (due to the presence of fever, redness, previous puncture wounds, or cellulitis), the olecranon bursa should be aspirated and the fluid sent for culture, for a cell count (WBCs, red blood cells [RBCs]), and for immediate Gram staining for bacteria. If the Gram stain is positive for bacteria, antibiotics should be started immediately and no corticosteroids should be injected into the bursa.
However, even if the Gram stain is negative or initially unavailable, withholding corticosteroid injection and starting antibiotics may seem indicated based on the mechanism of injury (eg, abrasion or puncture), physical examination findings suggestive of infection (eg, fever, significant local redness and warmth), or the gross appearance of the aspirate (eg, turbid, purulent).
WBC Count and Bacterial Culture
The leukocyte count can help to determine whether the fluid is infectious or merely inflammatory. Within synovial aspirates, WBC counts are assessed as follows:
Normal - Less than 200/µL
Noninflammatory - 200-2000/µL
Indication of inflammation - Count in the range of 2000-100,000/µL
Indication of a septic condition - Count greater than 100,000/µL
Bacterial culture and sensitivity testing of the aspirate can be performed to ensure the relevant bacteria are sensitive to the chosen antibiotic. These results can guide the modification of antibiotics in cases of bacterial infection.
After an acute injury, blood may be found within the aspirate, indicating a hemorrhagic bursitis (see the image below).
Analysis for crystals may reveal monosodium urate crystals in patients with gout, calcium pyrophosphate crystals in pseudogout, or hydroxyapatite crystals (see the image below).
Plain radiographs of the elbow should be performed to assess for a possible olecranon fracture if significant trauma occurred or if an avulsed osteophyte is present at the triceps insertion into the olecranon, which is fairly common. (See the image below.)
The use of ultrasonography has been shown to be extremely effective in the diagnosis of olecranon bursitis and other soft-tissue lesions in the olecranon area by rapidly demonstrating the presence of effusions, synovial proliferation, loose bodies, increased blood flow consistent with inflammation, tendonitis with calcifications, and other indications of bursitis.
Magnetic resonance imaging
In atypical cases, a magnetic resonance imaging (MRI) study may be indicated to help exclude concomitant pathology, such as a stress fracture, triceps tendinopathy or tear, or the rare case of osteomyelitis/abscess or tumor, especially if there is a long history of septic bursitis or to evaluate an unusual mass seen on plain radiographs.
The olecranon bursa can be aspirated using a long 18-gauge needle that is inserted after sterile skin preparation, using a circular motion with an antibacterial solution (after determining no applicable allergies exist) and appropriate local infiltration with a suitable agent, such as 1% lidocaine, using sterile technique to avoid secondary infection and a 27- to 30-gauge needle to make a skin wheal over the lateral bursa. The 18-gauge needle is attached to a 10-mL syringe and inserted into the dependent area of the bursa through a posterolateral approach, via an oblique needle angle or zigzag approach.
As opposed to a direct, perpendicular approach that is used for most joint aspirations, this technique creates a longer needle tract through the skin and subcutaneous layers, thus minimizing the risk of fistula formation. The medial approach to the olecranon bursa should be avoided, since a misdirected needle could damage the ulnar nerve. Aspiration of bursal contents is continued until the bursal site is flat. The needle is then withdrawn and the wound dressed with adhesive sterile bandage and the elbow wrapped with a compressive dressing. Active elbow range of motion should be restricted for about 2 days post injection. (See the images below.)[6, 7, 8]
If any cloudy fluid is aspirated, it should be sent for immediate Gram stain, leukocyte count, culture, and antibiotic sensitivity testing. No corticosteroids should be given until these tests prove negative. Aspiration can also be therapeutic, because it relieves the swelling. If cultures of aspirated fluid are negative and fluid recurs, the bursal aspiration can be repeated and, if sterile on culture, corticosteroids can be considered for joint injection.
If the clinician is confident that no infection is present, corticosteroid injection can be considered (for instance, immediately after aspiration of the fluid).
In the absence of a traumatic etiology, consideration should be given to analyzing the aspirated fluid for infection and crystals.
When aspiration/injection is performed, aseptic techniques should be used to minimize the chance of causing iatrogenic infection. Septic olecranon bursitis due to Mycobacterium smegmatis has been reported after intrabursal steroid injection.
Snider RK. Olecranon bursitis. Snider RK, ed. Essentials of Musculoskeletal Care. 2nd ed. Rosemont, Ill: American Academy of Orthopaedic Surgeons; 1997. 156-9.
McGee DJ. Elbow joints. Orthopedic Physical Assessment. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1992. 143-167.
Strakowski JA, Wiand JW, Johnson EW. Upper limb musculoskeletal pain syndromes. Braddom RL, ed. Physical Medicine and Rehabilitation. Philadelphia, Pa: WB Saunders Co; 1996. 756-82.
Morgan WJ. Elbow and forearm. Steinberg GG, Akins C, Baran D, eds. Orthopaedics in Primary Care. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1998. 70-98.
Brinker MR, Miller MD. The adult elbow. Fundamentals of Orthopaedics. Philadelphia, Pa: WB Saunders Co; 1999. 153-64.
Wasserman AR, Melville LD, Birkhahn RH. Septic bursitis: a case report and primer for the emergency clinician. J Emerg Med. 2009 Oct. 37(3):269-72. [Medline].
Wagner C, Iking-Konert C, Hug F, et al. Cellular inflammatory response to persistent localized Staphylococcus aureus infection: phenotypical and functional characterization of polymorphonuclear neutrophils (PMN). Clin Exp Immunol. 2006 Jan. 143(1):70-7. [Medline]. [Full Text].
Wessolossky M, Haran JP, Bagchi K. Paecilomyces lilacinus olecranon bursitis in an immunocompromised host: case report and review. Diagn Microbiol Infect Dis. 2008 Jul. 61(3):354-7. [Medline].
Turan H, Serefhanoglu K, Karadeli E, Timurkaynak F, Arslan H. A case of brucellosis with abscess of the iliacus muscle, olecranon bursitis, and sacroiliitis. Int J Infect Dis. 2009 Nov. 13(6):e485-7. [Medline].
Malkin J, Shrimpton A, Wiselka M, Barer MR, Duddridge M, Perera N. Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behcet's disease. J Med Microbiol. 2009 Mar. 58:371-3. [Medline].
Gregory T, Mir O, Medioni J, Augereau B, Oudard S. Olecranon bursitis in patients treated with sunitinib for renal cell carcinoma. Med Oncol. 2010 Jun. 27(2):446-8. [Medline].
Larsen BT, Smith ML, Grys TE, Vikram HR, Colby TV. Histopathology of Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Immunotherapy for Urothelial Carcinoma. Int J Surg Pathol. 2015 May. 23 (3):189-95. [Medline].
Schumacher HR. Arthrocentesis, synovial fluid analysis, and synovial biopsy. Schumacher HR, ed. Primer on Rheumatic Diseases. 10th ed. Atlanta, Ga: Arthritis Foundation; 1993. 67-72.
Blankstein A, Ganel A, Givon U, Mirovski Y, Chechick A. Ultrasonographic findings in patients with olecranon bursitis. Ultraschall Med. 2006 Dec. 27(6):568-71. [Medline].
Olsen NK, Press JM, Young JL. Bursal injections. Lennard TA, ed. Physiatric Procedures in Clinical Practice. Philadelphia, Pa: Hanley & Belfus; 1995. 36-43.
Degreef I, De Smet L. Complications following resection of the olecranon bursa. Acta Orthop Belg. 2006 Aug. 72(4):400-3. [Medline].
Ogilvie-Harris DJ, Gilbart M. Endoscopic bursal resection: the olecranon bursa and prepatellar bursa. Arthroscopy. 2000 Apr. 16(3):249-53. [Medline].
Baumbach SF, Lobo CM, Badyine I, et al. Prepatellar and olecranon bursitis: literature review and development of a treatment algorithm. Arch Orthop Trauma Surg. 2014 Mar. 134(3):359-70. [Medline].
Rhyou I, Park K, Kim K, Lee J, S Kim. Endoscopic Olecranon Bursal Resection for Olecranon Bursitis. J Hand Surg Asian-Pac. 2016 Jun. 21:167-72.
Kim JY, Chung SW, Kim JH, et al. A Randomized Trial Among Compression Plus Nonsteroidal Antiinflammatory Drugs, Aspiration, and Aspiration With Steroid Injection for Nonseptic Olecranon Bursitis. Clin Orthop Relat Res. 2016 Mar. 474 (3):776-83. [Medline].
Green SM. Nonsteroidal anti-inflammatory drugs (NSAIDs). Tarascon Pocket Pharmacopoeia 2000. Loma Linda, Calif: Tarascon; 2000. 11-2.
Perez C, Huttner A, Assal M, Bernard L, Lew D, Hoffmeyer P, et al. Infectious olecranon and patellar bursitis: short-course adjuvant antibiotic therapy is not a risk factor for recurrence in adult hospitalized patients. J Antimicrob Chemother. 2010 May. 65(5):1008-14. [Medline]. [Full Text].
Lennard TA. Fundamentals of procedural care. Physiatric Procedures in Clinical Practice. Philadelphia, Pa: Hanley & Belfus; 1995. 1-13.
Wasserzug O, Balicer RD, Boxman J, Klement E, Ambar R, Zimhony O. A cluster of septic olecranon bursitis in association with infantry training. Mil Med. 2011 Jan. 176(1):122-4. [Medline].